Updated Jul 31, 2018

CSense: Rapid, simple and low cost strip for early screening of Cervical Cancer at the Point of care

The innovation has no owner

CLAIM IT

Snapshot

Focus Areas:

Infectious & Vector Diseases and Sexual and Reproductive Health

Infectious & Vector Diseases and Sexual and Reproductive HealthSEE LESS

Implemented In:

India

IndiaSEE LESS

1
Country Implemented In
Verified Funding

Innovation Description

Cervical cancer is the 2nd largest cause of cancer deaths in women around the world. Globally 288000 women die of cervical cancer.In India 74000 females succumb, which is 1/3rd of the global burden. Most of these deaths are preventable. While methods like Pap and HPV DNA test are employed for cervical screening, they need a lab, trained manpower and suffer with many drawbacks. Thus there is a critical need for a rapid, accurate and low cost diagnostic test that can be used at the point of care.

Milestones

Jun 2018
Funds RaisedVERIFIED
$74,432
Date Unknown
New Country
India